de Juan Ferré, A.
Álvarez Álvarez, R.
Casado Herráez, A.
Cruz Jurado, J.
Estival González, A.
Martín-Broto, J.
Martínez Marín, V.
Moreno Vega, A.
Sebio García, A.
Valverde Morales, C.
Article History
Received: 20 November 2020
Accepted: 21 November 2020
First Online: 6 January 2021
Compliance with ethical standards
:
: Alberto Moreno: Speaker honoraria and/or travel support: Pharmamar, Roche, Astra-Zeneca, MSD, Kyowa-Kirin, Pfizer. Grants for Clinical Research: FIBICO, IMIBIC. Ana de Juan: reports personal fees and other from Roche, AstraZeneca, MSD, Pharma Mar, Clovis Oncology, Tesaro, GSK, Eisai Ltd, Pierre- Fabre, Lilly and Pfizer, outside the submitted work. Anna Estival: Travel expenses and educational activities: PharmaMar, Roche, Lilly, BMS. Honorary ( advisory): Roche, MSD, Astrazeneca. Ana Sebio: Research grants: Pharmamar, Terumo. Lectures and education: Pharmamar, Eisai, Lilly. Travel Expenses: Pharmamar, Merck, Roche, Lilly, Pfizer, Eisai, Amgen, Sanofi. Antonio Casado: He recibido ayuda de Pharmamar, Novartis, Roche, Astra -Zeneca, Clovis Oncology, GSK-Tesaro, Lilly y en menor medida de Eisai para atender reuniones científicas/congresos nacionales e internacionales. He participado en "Advisory Boards" de Pharmamar, Lilly, Roche, Novartis y Eisai. Mi institución ha recibido modestas cantidades económicas para proyectos de investigación (Pharmamar) y organización de eventos (Pharmamar, Lilly, Roche, Novartis y Eisai) en los últimos 5 años. Josefina Cruz: Entity: Glaxo, AstraZeneca, Roche, Novartis, Pharmamar, Eisai, Lilly, Celgene, Astellas, Amgen, and Pfizer (speaker honoraria). Consultant/advisory role: Entity: AstraZeneca, Roche, Novartis, Pharmamar, Eisai, Lilly, Celgene,Astellas, Amgen, Glaxo, and Pfizer. Rosa Alvarez: Speaker honoraria: Bristol, Roche, Pharmamar, Eisai. Advisory role: AstraZeneca, Roche, Pharmamar, Eisai, Lilly. Travel Expenses: Pharmamar, Roche. Virgínia Martínez: Speaker honoraria: Pfizer, Roche, Pharmamar, Novartis, Lilly. Travel Expenses: Pfizer, Roche. Javier Martín Broto: Honoraria (Advisory): Pharmamar, Lilly, Bayer, Eisai. Travel expenses: PharmaMar. Research: PharmaMar, Lilly, Eisai, Novartis, GSK, Lixte, Karyopharm, Celgene, Pfizer, BMS, Bluprint, Deciphera, Nektar, Forma, Amgen, Daiicho Sankyo. Claudia Mª Valverde: Honoraria (Advisory): Pharmamar, Lilly, Bayer, Eisai, Mundipharma, Pfizer. Travel expenses: Pharmamar, Lilly, Bayer. Research (to my institution): PharmaMar, Lilly, Eisai, Novartis, GSK, Karyopharm, Pfizer, Bluprint, Deciphera, Adaptimmune.
: The current study has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: For this type of retrospective study, formal consent is not required.